Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Jonathan McDunn, Ph.D., Associate Director, Diagnostics Research and Development at Metabolomic Inc. & Adjunct Associate Professor, UNC Department of Biomedical Engineering

When Feb 20, 2013 from 02:00 PM to 03:00 PM (US/Eastern / UTC-500)
Where G605 Koury (1st floor new Dental School Building)
Add event to calendar iCal

Sponsored by the Center for Environmental Health and Susceptibility (CEHS)